Mary Custer

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

Michael T. Lotze, Yvedt L. Matory, Stephen E. Ettinghausen et al. · The Journal of Immunology · 1985 · 614 citations

Life Sciences, Immunology, Pharmacology +9

Efficient Transfer of a Tumor Antigen-Reactive TCR to Human Peripheral Blood Lymphocytes Confers Anti-Tumor Reactivity

Timothy M. Clay, Mary Custer, Jessica Sachs et al. · The Journal of Immunology · 1999 · 407 citations · Full text

Life Sciences, Immunology, Oncology +17

Conditional Expression of the CTCF-Paralogous Transcriptional Factor BORIS in Normal Cells Results in Demethylation and Derepression of MAGE-A1 and Reactivation of Other Cancer-Testis Genes

Sergei Vatolin, Ziedulla Abdullaev, Svetlana Pack et al. · Cancer Research · 2005 · 200 citations

Life Sciences, Genetics, Molecular Biology +17

Reciprocal Binding of CTCF and BORIS to the NY-ESO-1 Promoter Coincides with Derepression of this Cancer-Testis Gene in Lung Cancer Cells

Julie A. Hong, Kang Yang, Ziedulla Abdullaev et al. · Cancer Research · 2005 · 198 citations

Medicine, Genetics, Oncology +17

RANTES Secretion by Gene-Modified Tumor Cells Results in Loss of Tumorigenicity <i>In Vivo:</i> Role of Immune Cell Subpopulations

James J. Mulé, Mary Custer, Bruce J. Averbook et al. · Human Gene Therapy · 1996 · 135 citations · Full text

Life Sciences, Immunology, Oncology +17